Drug Pipeline

Valemetostat tosylate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
3
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 2
3
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07303387 Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. Solid Tumor Malignancies Recruiting
NCT06632977 Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial Castration-Resistant Prostate Carcinoma Recruiting
NCT04842877 Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory… Lymphoma, B-Cell Active, Not Recruiting
Phase 1
NCT06244485 A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid… Advanced Solid Tumor Recruiting
NCT02732275 DS-3201b in Participants With Lymphomas Lymphoma, Malignant Active, Not Recruiting
Sponsors Running Valemetostat tosylate Trials
Disease Areas
Get alerts when Valemetostat tosylate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free